In the setting of acute myocardial infarction, pre‐treatment with guanabenz (which enhances eIF2α phosphorylation and increases ATF4 levels) largely corrected the deficit in Nox4 KO hearts but had no additional effect in WT hearts. Here, ATF4 is linked to acute myocardial infarction.